Global Advanced Genomics Market 2025 – 2034

Size and Growth of the Market

According to the CMI team's Advanced Genomics Market size study, the global advanced genomics market is expected to grow at a rate of 16.21% per year from 2025 to 2034. The market size was $48.31 billion in 2025. The value is expected to reach USD 186.70 billion by 2034.

Summary

According to CMI's experts in the field, the global advanced genomics market will grow at a very high rate between 2025 and 2034. This could be because DNA sequencing technologies are getting better, personalized medicine is becoming more popular, the government is giving more money to genomics research, and genomics is being used in more areas, like drug discovery and agriculture. New long-read technologies are making genomic analysis even more accurate and efficient.

Important Trends and Drivers

Growing Awareness and Adoption of Next-generation Sequencing to Determine Growth: More and more people are becoming aware of genomics' potential, which is driving up the need for genetic services and services related to them. The market is growing even more because NGS technologies are being used more widely in clinical and research settings. It has been said that NGS cuts down on the time and money needed for DNA sequencing by a large amount, making it easier to use in research.

Personalized medicines will be the best: Advanced genomics can look at a person's genetic makeup and make personalized development plans, which leads to more targeted and effective treatments. Understanding the genetic causes of diseases makes it easier to take steps to avoid them by diagnosing them early.

The scope of the report

Details of the Report Feature

The market will be worth $48.31 billion in 2025.

Estimated Market Size in 2034: $186.70 Billion

41.57 billion dollars in the market in 2024

CAGR Growth Rate: 16.21%

Year of Base: 2024

Time Frame for Forecast: 2025–2034

Key Segment: By Offering, Technology, Application, End-user, and Region

Report Coverage: Company Profile, Revenue Estimation and Forecast, Competitive Landscape, Growth Factors, and Recent Trends

Geographical Scope: North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America

Buying Options: Ask for personalized buying options that meet your research needs.

A SWOT analysis

Strengths: NGS and other cutting-edge technologies have made genomic analysis much faster, more accurate, and cheaper. The best part is that things are likely to stay the same in the future. Additionally, ongoing research is constantly adding to what we know about how genes work and how they cause diseases, which opens up new ways to treat and diagnose diseases. These are the strengths of the advanced genomics market, aside from the need for personalized medicines.

Weaknesses: The high cost of genomic sequencing and analysis could make it too expensive for some people and institutions, which would limit its use. Also, you need special bioinformatics tools to analyze and understand genomic data, which could be a problem for some people who want to get into the field. It may not always be possible to pay back the costs of genomic services and tests. This could also be one of the problems.

Opportunities: Advanced genomics provides unparalleled opportunities for pinpointing genetic etiologies of rare diseases, facilitating accurate diagnoses. ML and AI can speed up the process of analyzing data, predicting diseases in genomics, and finding new drugs. New gene therapies that use genome editing techniques are also possible thanks to advanced technologies. These therapies could cure genetic diseases.

Threats: Using genomic information is likely to raise moral issues about data security, privacy, and the possibility of the genetic information being used in the wrong way. The companies may also have a hard time dealing with the complicated rules for genomic therapies and tests. These could be the risks to the advanced genomics market. Show more